Omnicell is trading at $43.13 (down 5%) as the stock continues to face pressure following a recent earnings-driven selloff.
- The decline follows a Q4 2025 earnings miss and weaker-than-expected 2026 guidance issued in early February.
- Investors remain focused on the company's profitability and outlook, causing the stock to lag behind the broader market's upward trend today.